NCT00901186 - Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Diabetic Macular EdemaVisual Impairment

Interventions

DRUG

RFB002

0.5 mg

PROCEDURE

Laser photocoagulation

Trial Locations (17)

11009

Novartis Investigative Site, Cadiz

28002

Novartis Investigative Site, Madrid

28035

Novartis Investigative Site, Madrid

29010

Novartis Investigative Site, Málaga

31080

Novartis Investigative Site, Pamplona

35016

Novartis Investigative Site, Las Palmas de Gran Canaria

38320

Novartis Investigative Site, San Cristóbal de La Laguna

46026

Novartis Investigative Site, Valencia

47011

Novartis Investigative Site, Valladolid

48903

Novartis Investigative Site, Barakaldo

04009

Novartis Investigative Site, Almería

07198

Novartis Investigative Site, Mallorca

08021

Novartis Investigative Site, Barcelona

08025

Novartis Investigative Site, Barcelona

08907

Novartis Investigative Site, L'Hospitalet de Llobregat

08221

Novartis Investigative Site, Terrassa

Unknown

Novartis Investigative Site, Madrid